PKTX Stock Price, Chart, Stats & News

ProtoKinetix, Incorporated
Save
ProtoKinetix, Incorporated (PKTX) does not currently pay a dividend.
78,316
Market cap
–
Current P/E
–
Forward P/E
PKTX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia.
Similar securities
Based on sector and market capitalization
Report issue





